SZSE Ticker: 300147

Xiangxue Pharmaceutical Co., Ltd.

广州市香雪制药股份有限公司

香雪制药

XXZY

Listing Date: 2010-12-15

Board: GEM

Industry Classification: Manufacturing

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

Xiangxue Pharma: The company has no products to treat hepatitis at the moment IT News

Post date May 6, 2022 — 18:49 Post Lock

Xiangxue Pharmaceutical: The company has no products to treat hepatitis at the moment_Oriental Fortune Net

Post date May 6, 2022 — 18:48 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top Ten Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 10:10 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top Ten Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 10:10 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: New Progress Steps Higher

Post date May 3, 2022 — 08:46 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top Ten Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 08:01 Post Lock

Securities Finance and Asset Management’s Investment Roadmap for the First Quarter Announced: Top 10 Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 04:10 Post Lock

Securities Finance and Asset Management’s Investment Roadmap for the First Quarter Announced: Top 10 Shareholders of New Progressive High Stocks

Post date May 2, 2022 — 23:10 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top 10 Shareholders of New Progressive High Stocks

Post date May 2, 2022 — 22:55 Post Lock

Securities Finance and Asset Management’s investment roadmap for the first quarter announced: the top ten shareholders of new progressive stocks

Post date May 2, 2022 — 20:04 Post Lock

Securities Finance and Asset Management’s investment roadmap for the first quarter announced: the top ten shareholders of high-end stocks before the new increase, the guitar score in an instant, the water to protect the field will be green, the border is blocked, the baby is crying, the second is learning games

Post date May 2, 2022 — 20:01 Post Lock

Capital seeks insurance licenses to cool down many insurance companies' equity auctions Rongyi Industry Rongyi Information Network

Post date April 24, 2022 — 23:37 Post Lock

Capital seeks insurance licenses to cool down many insurance companies' equity auctions Rongyi Industry Rongyi Information Network

Post date April 24, 2022 — 23:33 Post Lock

Xiangxue Pharmaceutical's loss in 2021 is 688 million year-on-year, and chairman Wang Yonghui's salary is 862,500-

Post date April 23, 2022 — 18:12 Post Lock

Xiangxue Pharmaceutical (300147): Resolution of the Board of Directors CFi.CN

Post date April 23, 2022 — 08:06 Post Lock

[News] Xiangxue Pharma Announces Annual Report CFi.CN

Post date April 23, 2022 — 08:06 Post Lock

The concept of new crown drug treatment continued to decline in the afternoon, and many stocks fell more than 7%

Post date April 19, 2022 — 15:30 Post Lock

Sector changes, the National Medical Insurance Bureau said that it will continue to reduce the price of therapeutic drugs. New crown drug treatment concept stocks continued to decline in the afternoon.

Post date April 19, 2022 — 15:30 Post Lock

Want to see more data? Registered subscribers can see all the data.